Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice.

[1]  A. Mantovani,et al.  Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock , 1991, The Journal of experimental medicine.

[2]  D. Remick,et al.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. , 1991, Journal of immunology.

[3]  R. Danner,et al.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents , 1991, The Journal of experimental medicine.

[4]  J. Abrams,et al.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. , 1990, Journal of immunology.

[5]  A. Waage,et al.  Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts , 1990, European journal of immunology.

[6]  A. Waage,et al.  Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo , 1989 .

[7]  J. Meer,et al.  In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation , 1989 .

[8]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[9]  S. Zuckerman,et al.  Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.

[10]  A. Mantovani,et al.  IL-1 stimulates IL-6 production in endothelial cells. , 1989, Journal of immunology.

[11]  P. Brandtzaeg,et al.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome , 1989, The Journal of experimental medicine.

[12]  J. Vilček,et al.  Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Koizumi,et al.  Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. , 1988, Immunology.

[14]  L. Aarden,et al.  Interleukin 6 is involved in interleukin 1‐induced activities , 1988, European journal of immunology.

[15]  J. Vilček,et al.  Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. , 1988, The Journal of biological chemistry.

[16]  P. Ghezzi,et al.  Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[17]  D. Remick,et al.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.

[18]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J H Korn,et al.  Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines. , 1986, The EMBO journal.

[20]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[21]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[22]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[23]  B. Aggarwal,et al.  Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. , 1984, The Journal of biological chemistry.

[24]  P. Halushka,et al.  Ibuprofen improves survival from endotoxic shock in the rat. , 1980, Journal of Pharmacology and Experimental Therapeutics.

[25]  G. Spinas,et al.  Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia. , 1991, The Journal of infectious diseases.